Researchers have modified a common chemotherapy drug to create a new probe for Positron Emission Tomography, an advance that will allow them to model and measure the immune system in action and monitor response to new therapies.
Researchers have modified a common chemotherapy drug to create a new probe for Positron Emission Tomography, an advance that will allow them to model and measure the immune system in action and monitor response to new therapies.